These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Hedrick JA, Watry D, Speiser C, O'Donnell P, Lambris JD, Tsoukas CD. Eur J Immunol; 1992 May 01; 22(5):1123-31. PubMed ID: 1315687 [Abstract] [Full Text] [Related]
5. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. Weiss ER, Alter G, Ogembo JG, Henderson JL, Tabak B, Bakiş Y, Somasundaran M, Garber M, Selin L, Luzuriaga K. J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27733645 [Abstract] [Full Text] [Related]
9. Characterization of an Epstein-Barr virus receptor on human epithelial cells. Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E. J Exp Med; 1992 Nov 01; 176(5):1405-14. PubMed ID: 1383386 [Abstract] [Full Text] [Related]
10. Stable expression and function of EBV/C3d receptor following genomic transfection into murine fibroblast L cells. Cantaloube JF, Piechaczyk M, Calender A, Lenoir G, Minty A, Carrière D, Fischer E, Poncelet P. Eur J Immunol; 1990 Feb 01; 20(2):409-16. PubMed ID: 1690137 [Abstract] [Full Text] [Related]
11. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells. Carel JC, Frazier B, Ley TJ, Holers VM. J Immunol; 1989 Aug 01; 143(3):923-30. PubMed ID: 2473114 [Abstract] [Full Text] [Related]
12. Epstein-Barr virus replicative gene transcription during de novo infection of human thymocytes: simultaneous early expression of BZLF-1 and its repressor RAZ. Kelleher CA, Paterson RK, Dreyfus DH, Streib JE, Xu JW, Takase K, Jones JF, Gelfand EW. Virology; 1995 Apr 20; 208(2):685-95. PubMed ID: 7747440 [Abstract] [Full Text] [Related]
13. Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection. Nemerow GR, Mullen JJ, Dickson PW, Cooper NR. J Virol; 1990 Mar 20; 64(3):1348-52. PubMed ID: 2154612 [Abstract] [Full Text] [Related]
14. Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule. Tanner JE, Coinçon M, Leblond V, Hu J, Fang JM, Sygusch J, Alfieri C. J Virol; 2015 May 20; 89(9):4932-41. PubMed ID: 25694592 [Abstract] [Full Text] [Related]
20. Infection of the HTLV-I-harbouring T-lymphoblastoid line MT-2 by Epstein-Barr virus. Koizumi S, Zhang XK, Imai S, Sugiura M, Usui N, Osato T. Virology; 1992 Jun 20; 188(2):859-63. PubMed ID: 1316683 [Abstract] [Full Text] [Related] Page: [Next] [New Search]